Pfizer (Global License of Ervogastat) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Pfizer (Global License of Ervogastat) General Information

Description

A phase 2 oral DGAT-2 inhibitor.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • New York, NY
  • United States
Primary Industry
Buildings and Property
Acquirer
Madrigal Pharmaceuticals
Corporate Office
  • New York, NY
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer (Global License of Ervogastat) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pfizer (Global License of Ervogastat)‘s full profile, request access.

Request a free trial

Pfizer (Global License of Ervogastat) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pfizer (Global License of Ervogastat)‘s full profile, request access.

Request a free trial

Pfizer (Global License of Ervogastat) FAQs

  • Where is Pfizer (Global License of Ervogastat) headquartered?

    Pfizer (Global License of Ervogastat) is headquartered in New York, NY.

  • What industry is Pfizer (Global License of Ervogastat) in?

    Pfizer (Global License of Ervogastat)’s primary industry is Buildings and Property.

  • Is Pfizer (Global License of Ervogastat) a private or public company?

    Pfizer (Global License of Ervogastat) is a Private company.

  • What is Pfizer (Global License of Ervogastat)’s current revenue?

    The current revenue for Pfizer (Global License of Ervogastat) is .

  • Who are Pfizer (Global License of Ervogastat)’s investors?

    Pfizer has invested in Pfizer (Global License of Ervogastat).

  • When was Pfizer (Global License of Ervogastat) acquired?

    Pfizer (Global License of Ervogastat) was acquired on 09-Jan-2026.

  • Who acquired Pfizer (Global License of Ervogastat)?

    Pfizer (Global License of Ervogastat) was acquired by Madrigal Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process